Mid-term clinical results of the cementless R3 cup and Polarstem total hip arthroplasty.


Journal

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie
ISSN: 1432-1068
Titre abrégé: Eur J Orthop Surg Traumatol
Pays: France
ID NLM: 9518037

Informations de publication

Date de publication:
May 2019
Historique:
received: 01 10 2018
accepted: 03 12 2018
pubmed: 12 12 2018
medline: 4 12 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

There has been a shift from cemented to uncemented hip arthroplasty. One popular uncemented combination is the R3 acetabular cup with Polarstem, having the lowest revision rate in the UK National Joint Registry. However, there are no medium-term clinical outcomes on this combination in the literature. The aim of this study is to review our centre's outcomes with this combination using conventional bearings with a minimum of 7-year follow-up. Using our centre's arthroplasty database, we identified all patients that underwent a total hip arthroplasty using these implants from August 2009 to December 2010. One hundred and forty-four procedures were performed. The primary outcome was revision rate, and the secondary outcomes were clinical and radiological evaluation. The mean cohort age at surgery was 68.3 years. There were three revisions, of which only one underwent a cup revision. The mean Oxford Hip Score at 7-year follow-up was 38. Radiological evaluation of both acetabular and stem component did not show any radiolucency at 7-year follow-up. Kaplan-Meier survivorship analysis showed an implant survival rate of 97.69% at 7 years using revision for all causes as endpoint. The risk of revision was 1.47% at 7 years. Our revision rates are comparable to the UK's National Joint Registry, with excellent clinical and radiological outcome. Our results correlate with the allocated rating of 7A* by the Orthopaedic Data Evaluation Panel for both R3 acetabular cup and Polarstem.

Sections du résumé

BACKGROUND BACKGROUND
There has been a shift from cemented to uncemented hip arthroplasty. One popular uncemented combination is the R3 acetabular cup with Polarstem, having the lowest revision rate in the UK National Joint Registry. However, there are no medium-term clinical outcomes on this combination in the literature. The aim of this study is to review our centre's outcomes with this combination using conventional bearings with a minimum of 7-year follow-up.
METHODS METHODS
Using our centre's arthroplasty database, we identified all patients that underwent a total hip arthroplasty using these implants from August 2009 to December 2010. One hundred and forty-four procedures were performed. The primary outcome was revision rate, and the secondary outcomes were clinical and radiological evaluation.
RESULTS RESULTS
The mean cohort age at surgery was 68.3 years. There were three revisions, of which only one underwent a cup revision. The mean Oxford Hip Score at 7-year follow-up was 38. Radiological evaluation of both acetabular and stem component did not show any radiolucency at 7-year follow-up. Kaplan-Meier survivorship analysis showed an implant survival rate of 97.69% at 7 years using revision for all causes as endpoint. The risk of revision was 1.47% at 7 years.
CONCLUSION CONCLUSIONS
Our revision rates are comparable to the UK's National Joint Registry, with excellent clinical and radiological outcome. Our results correlate with the allocated rating of 7A* by the Orthopaedic Data Evaluation Panel for both R3 acetabular cup and Polarstem.

Identifiants

pubmed: 30535590
doi: 10.1007/s00590-018-2357-x
pii: 10.1007/s00590-018-2357-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

827-833

Références

Qual Health Care. 1996 Jun;5(2):81-8
pubmed: 10158596
J Bone Joint Surg Br. 2001 Apr;83(3):345-7
pubmed: 11341417
J Bone Joint Surg Am. 2005 Sep;87(9):1999-2005
pubmed: 16140815
Osteoarthritis Cartilage. 2011 Feb;19(2):155-62
pubmed: 20951814
J Arthroplasty. 2012 Jan;27(1):74-81
pubmed: 21550766
Orthop Rev (Pavia). 2011 Sep 6;3(2):e16
pubmed: 22355482
Acta Orthop. 2013 Jun;84(3):229-36
pubmed: 23594249
J Arthroplasty. 2014 Mar;29(3):609-11
pubmed: 23993433
Acta Orthop. 2014 Jun;85(3):244-9
pubmed: 24786908
J Arthroplasty. 2015 Sep;30(9):1652-6
pubmed: 25890504
Hip Int. 2016 Sep 29;26(5):451-457
pubmed: 27229164
J Arthroplasty. 2017 May;32(5):1679-1683
pubmed: 28159422
Hip Int. 2017 Jul 29;:0
pubmed: 28777383
Bone Joint J. 2017 Nov;99-B(11):1435-1441
pubmed: 29092981
Bone Joint J. 2018 Jan;100-B(1):6-10
pubmed: 29305444
J Bone Joint Surg Am. 1973 Dec;55(8):1629-32
pubmed: 4217797
Clin Orthop Relat Res. 1979 Jun;(141):17-27
pubmed: 477100
Bone. 1993 May-Jun;14(3):231-42
pubmed: 8363862
Clin Orthop Relat Res. 1976 Nov-Dec;(121):20-32
pubmed: 991504

Auteurs

Ali Assaf (A)

Trauma & Orthopaedic Department, The Hip Arthroplasty Unit, Royal Gwent Hospital, Newport, Wales, NP20 2UB, UK. assafali0418@gmail.com.

Jonathan R Manara (JR)

Trauma & Orthopaedic Department, The Hip Arthroplasty Unit, Royal Gwent Hospital, Newport, Wales, NP20 2UB, UK.

Kar H Teoh (KH)

Trauma & Orthopaedic Department, The Hip Arthroplasty Unit, Royal Gwent Hospital, Newport, Wales, NP20 2UB, UK.

Aled R Evans (AR)

Trauma & Orthopaedic Department, The Hip Arthroplasty Unit, Royal Gwent Hospital, Newport, Wales, NP20 2UB, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH